Ellen K. Donnelly, Ph.D
Chief Executive Officer
Ellen K. Donnelly, Ph.D., joined Modus Therapeutics April 2017 from Pfizer, Inc., where she held various leadership positions in Clinical Operations; Project and Portfolio Management; and Research. Most recently Dr. Donnelly was responsible for Clinical Operations for Pfizer’s Neuroscience and Pain therapeutic area. Dr. Donnelly also brings biotech and consulting experience to the CEO role, having worked in positions within U.S. biotech and management consulting prior to her time at Pfizer. Dr. Donnelly received her Ph.D. from Yale University.